- Patients must be at least 18 years of age at screening
- Males and female patients with clinical diagnosis of ulcerative colitis ≥3 months
prior to entry into the study.
- Male and female patients with active currently moderate to severe ulcerative colitis
defined by Mayo score of ≥6
- Patients with endoscopic sub-score of ≥2 on the Mayo score determined within 7 days of
baseline.
- Diagnosis of Crohn's disease or diagnosis of indeterminate colitis
- Treatment naive subjects who have not had previous exposure to treatment for
ulcerative colitis
- Patients that are currently receiving immunosuppressants, anti-TNF? therapy or
interferon